Search

Your search keyword '"Breccia, M."' showing total 28 results
Start Over Author "Breccia, M." Language italian
28 results on '"Breccia, M."'

5. Trattamento postoperatorio

Author

Breccia, M., Ferranti, S., Rossi, B., Farneti, A., Pennacchi, L., Berloco, M., Pasotti, L., Mattei, P., Picuti, G., Musiello, S., and Farneti, C.

Published
2016
Full Text
View/download PDF

12. THE BCR-ABL FUSION TRANSCRIPT HAS A PROGNOSTIC IMPACT IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB IN EARLY CHRONIC PHASE: A GIMEMA CML WP ANALYSIS

Author

Castagnetti, F, Gugliotta, G, Palandri, F, Breccia, M, Specchia, G, Abruzzese, E, Levato, L, Cavazzini, F, Orlandi, E, Stagno, F, Di Lorenzo, R, Annunziata, M, Usala, E, Sica, S, Galieni, P, Rege-Cambrin, G, Amabile, M, Soverini, S, Testoni, N, Alimena, G, Martinelli, G, Pane, F, Saglio, G, Baccarani, M, and Rosti, G for the GIMEMA CML Working Party

Published
2011

13. LOW-DOSE IMATINIB IN VERY ELDERLY (> 75 YEARS) CML PATIENTS: IS IT ENOUGH?

Author

Latagliata, R, Ferrero, D, Cavazzini, F, Trawinska, M, Breccia, M, Annunziata, M, Stagno, F, Tiribelli, M, Binotto, G, Crisà, E, Musto, P, Gozzini, A, Cavalli, L, Porrini, R, Iurlo, A, Musolino, C, Cedrone, M, Russo Rossi, A, Pregno, P, Endri, M, Spadea, A, Giglio, G, Celesti, F, Sorà, F, Gasbarrino, C, D’Addosio, A, Rege Cambrin, G, Luciano, L, Abruzzese, E, and Alimena, G

Published
2011

14. A RETROSPECTIVE ANALYSIS OF 603 PATIENTS WITH POLYCYTHEMIA VERA (PV) FOLLOWED IN THE LAZIO REGION FROM 1979 TO DATE: DEFINITION OF PROGNOSTIC FACTORS ON THROMBOSIS-FREE SURVIVAL (TFS) AND OVERALL SURVIVAL (OS)

Author

Andriani, A, Latagliata R, Cedrone, M, Spirito, F, Ruscio, C, Leonetti Crescenzi, S, Porrini, R, Di Giandomenico, J, Cotroneo, E, Villivà, N, Spadea, A, Rago, A, De Gregoris, C, Pessina, G, Di Muro, M, Felici, S, Breccia, M, Montefusco, E, Bagnato, A, Annino, L, Cimino, G, Majolino, I, Alimena, G, and Montanaro, M

Published
2011

27. [Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].

Author

Fama A, Rago A, Gioiosa F, Marzano C, Latagliata R, Mammì C, Laganà C, D'Elia GM, Bizzoni L, Trasarti S, Ferretti A, Breccia M, Riggio O, and Tafuri A

Subjects
Diagnosis, Differential, Humans, Bone Marrow Neoplasms diagnosis, Bone Marrow Neoplasms genetics, Budd-Chiari Syndrome diagnosis, Budd-Chiari Syndrome genetics, Janus Kinase 2 genetics, Myeloproliferative Disorders diagnosis, Myeloproliferative Disorders genetics, Splanchnic Circulation, Venous Thrombosis diagnosis, Venous Thrombosis genetics
Abstract

The Budd-Chiari Syndrome (BCS) and the splanchnic vein thrombosis are characterized by hepatic venous outflow obstruction, generally due to venous thrombosis. These rare diseases are usually caused by multiple concurrent factors, including acquired and inherited thrombophilias. Since the diagnosis of myeloproliferative neoplasms (MPNs) is often difficult in patients with BCS and splanchnic vein thrombosis because of spleen enlargement, secondary pancytopenia and bleeding disorders, recent observations have included in the diagnostic work-up the analysis of the JAK2 mutation. The revision of several recent reports clarify the importance of the JAK2V617F detection in the diagnostic work-up of the BCS and splanchnic vein thrombosis, allowing the demonstration of masked MPNs among these cases that may benefit, in the near future, of target molecular therapies directed toward the JAK2 mutation.

Published
2010

28. [Thyroid carcinoma. Clinical strategy and therapeutic course].

Author

Baschieri L, Breccia M, and De Negri F

Subjects
Antineoplastic Agents therapeutic use, Carcinoma epidemiology, Carcinoma therapy, Diagnosis, Differential, Follow-Up Studies, Humans, Iodine Radioisotopes therapeutic use, Thyroid Neoplasms epidemiology, Thyroid Neoplasms therapy, Thyroidectomy, Carcinoma diagnosis, Thyroid Neoplasms diagnosis
Published
1986

Catalog

Books, media, physical & digital resources
See catalog results